000			01841 a2200493 4500
005			20250515172730.0
264		0	_c20090820
008			200908s 0 0 eng d
022			_a1538-8689
024	7		_a10.1097/01.NURSE.0000352331.43115.f9 _2doi
040			_aNLM _beng _cNLM
100	1		_aHussar, Daniel A
245	0	0	_aNew drugs 09, part 2. _h[electronic resource]
260			_bNursing _cJun 2009
300			_a33-9; quiz 40 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdrenergic Uptake Inhibitors _xtherapeutic use
650	0	4	_aAngioedemas, Hereditary _xdrug therapy
650	0	4	_aBenzoates _xtherapeutic use
650	0	4	_aCarrier Proteins _xtherapeutic use
650	0	4	_aComplement C1 Inactivator Proteins _xtherapeutic use
650	0	4	_aComplement C1 Inhibitor Protein
650	0	4	_aDrug Approval
650	0	4	_aDrug Therapy _xnursing
650	0	4	_aDrug-Related Side Effects and Adverse Reactions
650	0	4	_aFluprednisolone _xanalogs & derivatives
650	0	4	_aHumans
650	0	4	_aHuntington Disease _xdrug therapy
650	0	4	_aHydrazines _xtherapeutic use
650	0	4	_aKeratitis _xdrug therapy
650	0	4	_aNurse's Role
650	0	4	_aOphthalmologic Surgical Procedures _xadverse effects
650	0	4	_aPain, Postoperative _xdrug therapy
650	0	4	_aPurpura, Thrombocytopenic, Idiopathic _xdrug therapy
650	0	4	_aPyrazoles _xtherapeutic use
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aReceptors, Fc _xtherapeutic use
650	0	4	_aRecombinant Fusion Proteins
650	0	4	_aTetrabenazine _xtherapeutic use
650	0	4	_aThrombopoietin
650	0	4	_aUveitis _xdrug therapy
773	0		_tNursing _gvol. 39 _gno. 6 _gp. 33-9; quiz 40
856	4	0	_uhttps://doi.org/10.1097/01.NURSE.0000352331.43115.f9 _zAvailable from publisher's website
999			_c18900119 _d18900119